传染科指南

订阅

MedSci主页 / 所有栏目 / 传染科指南

2021 NICE指南：COVID-19快速指南—COVID-19的管理（NG.191）

2021-11-22 英国国家卫生与临床优化研究所 NICE官网

Covid-19呼吸系感染性疾病

2021年11月，英国国家卫生与临床优化研究所 (NICE)发布了COVID-19快速指南—COVID-19的管理。

中文标题：

2021 NICE指南：COVID-19快速指南—COVID-19的管理（NG.191）

英文标题：

NICE guideline [NG191]：COVID-19 rapid guideline: managing COVID-19

发布机构：

英国国家卫生与临床优化研究所

发布日期：

2021-11-22

简要介绍：

2021年11月，英国国家卫生与临床优化研究所 (NICE)发布了COVID-19快速指南—COVID-19的管理。本文涵盖了儿童、青少年以及成人COVID-19的管理，汇集了COVID-19管理的现有建议和治疗的更新建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 NICE指南：COVID-19快速指南—COVID-19的管理（NG.191）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=151411c0022e091c, title=2021 NICE指南：COVID-19快速指南—COVID-19的管理（NG.191）, enTitle=NICE guideline [NG191]：COVID-19 rapid guideline: managing COVID-19, guiderFrom=NICE官网, authorId=0, author=, summary=2021年11月，英国国家卫生与临床优化研究所 (NICE)发布了COVID-19快速指南—COVID-19的管理。, cover=https://img.medsci.cn/20211124/1637746780788_1608702.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所（NICE，National Institute for Health and Clinical Excellence）是NHS的组织，设在伦敦和曼彻斯特。NICE成立于1999年4月1日，目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南，设定质量标准，管理国家数据库，为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Mon Nov 22 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年11月，英国国家卫生与临床优化研究所 (NICE)发布了COVID-19快速指南&mdash;COVID-19的管理。本文涵盖了儿童、青少年以及成人COVID-19的管理，汇集了COVID-19管理的现有建议和治疗的更新建议。</span></p>, tagList=[TagDto(tagId=99632, tagName=Covid-19), TagDto(tagId=117611, tagName=呼吸系感染性疾病)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=99632, guiderKeyword=Covid-19, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=33702, appHits=75, showAppHits=0, pcHits=487, showPcHits=33627, likes=0, shares=12, comments=7, approvalStatus=1, publishedTime=Wed Nov 24 17:44:14 CST 2021, publishedTimeString=2021-11-22, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Wed Nov 24 17:43:42 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Fri Jan 05 04:54:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 NICE指南：COVID-19快速指南—COVID-19的管理（NG.191）.pdf)])
2021 NICE指南：COVID-19快速指南—COVID-19的管理（NG.191）.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1186007, encodeId=1dcd118600e76, content=学习➕收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211126/ed525419364c40fabe9c492f1ab14454/f2d7e053250e42978439ecba216fc77c.jpg, createdBy=2e465079378, createdName=ada昵称, createdTime=Wed Jan 19 14:01:20 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079652, encodeId=602910e9652d1, content=学习一下啊啊啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed536400867, createdName=ms6000000315489971, createdTime=Mon Dec 13 19:02:50 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074923, encodeId=e29610e49239f, content=学习来了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/55Vo7AypySapiacTSbibnKB96WL6GS6fOUzpLSyMpCU4Zam9k96nlFgsuicBnKYd87oRn6nm0sFBG9IQjhVLibxtXg/132, createdBy=3b7f2509696, createdName=陈厅, createdTime=Mon Nov 29 01:05:26 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074050, encodeId=e68a10e4050ce, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Nov 26 06:59:57 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073781, encodeId=3b1310e37810e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aed5943817, createdName=huanglei9069, createdTime=Thu Nov 25 10:27:17 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2022-01-19 ada昵称

    学习➕收藏

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1186007, encodeId=1dcd118600e76, content=学习➕收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211126/ed525419364c40fabe9c492f1ab14454/f2d7e053250e42978439ecba216fc77c.jpg, createdBy=2e465079378, createdName=ada昵称, createdTime=Wed Jan 19 14:01:20 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079652, encodeId=602910e9652d1, content=学习一下啊啊啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed536400867, createdName=ms6000000315489971, createdTime=Mon Dec 13 19:02:50 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074923, encodeId=e29610e49239f, content=学习来了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/55Vo7AypySapiacTSbibnKB96WL6GS6fOUzpLSyMpCU4Zam9k96nlFgsuicBnKYd87oRn6nm0sFBG9IQjhVLibxtXg/132, createdBy=3b7f2509696, createdName=陈厅, createdTime=Mon Nov 29 01:05:26 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074050, encodeId=e68a10e4050ce, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Nov 26 06:59:57 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073781, encodeId=3b1310e37810e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aed5943817, createdName=huanglei9069, createdTime=Thu Nov 25 10:27:17 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2021-12-13 ms6000000315489971

    学习一下啊啊啊

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1186007, encodeId=1dcd118600e76, content=学习➕收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211126/ed525419364c40fabe9c492f1ab14454/f2d7e053250e42978439ecba216fc77c.jpg, createdBy=2e465079378, createdName=ada昵称, createdTime=Wed Jan 19 14:01:20 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079652, encodeId=602910e9652d1, content=学习一下啊啊啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed536400867, createdName=ms6000000315489971, createdTime=Mon Dec 13 19:02:50 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074923, encodeId=e29610e49239f, content=学习来了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/55Vo7AypySapiacTSbibnKB96WL6GS6fOUzpLSyMpCU4Zam9k96nlFgsuicBnKYd87oRn6nm0sFBG9IQjhVLibxtXg/132, createdBy=3b7f2509696, createdName=陈厅, createdTime=Mon Nov 29 01:05:26 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074050, encodeId=e68a10e4050ce, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Nov 26 06:59:57 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073781, encodeId=3b1310e37810e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aed5943817, createdName=huanglei9069, createdTime=Thu Nov 25 10:27:17 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2021-11-29 陈厅

    学习来了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1186007, encodeId=1dcd118600e76, content=学习➕收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211126/ed525419364c40fabe9c492f1ab14454/f2d7e053250e42978439ecba216fc77c.jpg, createdBy=2e465079378, createdName=ada昵称, createdTime=Wed Jan 19 14:01:20 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079652, encodeId=602910e9652d1, content=学习一下啊啊啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed536400867, createdName=ms6000000315489971, createdTime=Mon Dec 13 19:02:50 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074923, encodeId=e29610e49239f, content=学习来了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/55Vo7AypySapiacTSbibnKB96WL6GS6fOUzpLSyMpCU4Zam9k96nlFgsuicBnKYd87oRn6nm0sFBG9IQjhVLibxtXg/132, createdBy=3b7f2509696, createdName=陈厅, createdTime=Mon Nov 29 01:05:26 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074050, encodeId=e68a10e4050ce, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Nov 26 06:59:57 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073781, encodeId=3b1310e37810e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aed5943817, createdName=huanglei9069, createdTime=Thu Nov 25 10:27:17 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2021-11-26 微探

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1186007, encodeId=1dcd118600e76, content=学习➕收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211126/ed525419364c40fabe9c492f1ab14454/f2d7e053250e42978439ecba216fc77c.jpg, createdBy=2e465079378, createdName=ada昵称, createdTime=Wed Jan 19 14:01:20 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079652, encodeId=602910e9652d1, content=学习一下啊啊啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed536400867, createdName=ms6000000315489971, createdTime=Mon Dec 13 19:02:50 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074923, encodeId=e29610e49239f, content=学习来了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/55Vo7AypySapiacTSbibnKB96WL6GS6fOUzpLSyMpCU4Zam9k96nlFgsuicBnKYd87oRn6nm0sFBG9IQjhVLibxtXg/132, createdBy=3b7f2509696, createdName=陈厅, createdTime=Mon Nov 29 01:05:26 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074050, encodeId=e68a10e4050ce, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Nov 26 06:59:57 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073781, encodeId=3b1310e37810e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aed5943817, createdName=huanglei9069, createdTime=Thu Nov 25 10:27:17 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2021-11-25 huanglei9069

    学习

    0

相关指南

COVID-19 和代谢疾病：机制和临床管理

欧洲代谢专家组 · 2021-10-04

血管疾病或心血管危险因素和 COVID-19 患者管理指南：来自欧洲血管学/血管医学独立基金会（VAS）的立场文件

欧洲血管学/血管医学独立基金会（VAS） · 2021-11-01

COVID-19的血管方面问题：国际血管联盟立场文件

国际血管联盟(IUA,International Union of Angiology) · 2021-11-01

COVID-19 中的细胞因子风暴-免疫病理学机制、临床考虑和治疗方法：REPROGRAM 联盟立场文件

流行病卫生系统恢复计划 (Pandemic Health System REsilience PROGRAM，REPROGRAM) · 2021-11-01

COVID-19 中的内皮功能障碍：ESC 动脉粥样硬化和血管生物学工作组和 ESC 基础心血管科学委员会的立场文件

欧洲心脏病学会(ESC,European Society of Cardiology) · 2021-11-01

以色列立场文件：COVID-19 大流行期间重病患者的分诊决定

暂未更新 · 2021-11-01

拓展阅读

2019冠状病毒病(COVID-19)疫情防控期间妇科急诊患者临床诊疗防护原则和措施的建议

暂未更新 · 2020-02-18

COVID-19感染患者的气管切开术共识：西班牙

西班牙重症监护医学与冠心病小组学会(SEMICYUC,Spanish Society of Intensive Care Medicine and Coronary Units) · 2020-06-01

OVID-19大流行期间妇科恶性肿瘤的放射治疗：国际专家共识建议

暂未更新 · 2020-06-23

在COVID-19大流行期间接受治疗性放疗的肺癌患者管理共识

暂未更新 · 2020-09-01

肺癌和COVID-19大流行：巴西胸部肿瘤小组的建议

巴西胸部肿瘤组织（Brazilian Thoracic Oncology Group） · 2020-09-01

COVID-19患者的化学预防，诊断，治疗和出院管理：循证临床实践指南（更新版本）

中国医院协会(CHA,Chinese Hospital Association) ·